Service Introduction
Successful Cases
Team Advantage

Provide customers with customized real world study solutions through retrospective multi-source data research, prospective observational research and a combination of different methods.

Anti-coronavirus drug, using RWD synthetic arm to support FDA listing

Helping overseas approved antitumor drugs to be exempted from RCT

    in Hainan Lecheng Pioneer Zone

Our team brings together multidisciplinary experts in medical affairs, clinical research, Bioinformatics, Statistics, Health economics, Epidemiology, Data Science, and regulatory affairs. We have the unique domestic experience in using RWD synthetic arms to support FDA listing, and RWE to support drug indication expansion. At the same time, we have in-depth collaboration with Hainan Lecheng Medical Pioneer Zone to help overseas approved drugs and devices land in the Hainan Lecheng Medical Pioneer Zone, to realize the rapid listing of RWD instead of RCT in China. Collect post-marketing clinical drug data, convert RWD into RWE, help drugs realize application value and extend product life cycle.

Home
Contact us

Tel:010-53681050

Contact e-mail:contact@medataccess.com

Contact address: Room209B, 2nd floor, Building No. 4,
                           Zhubang 2000 BusinessCenter,
                           No. 100 Balizhuangxili, Chaoyang District,Beijing
Navigation
Scan the code for more
About us
News update
Join us

International standards and quality as a benchmark

Provide customers with all-in-one solutions for the full lifecycle of pharmaceutical products